The importance of monitoring adverse drug reactions in pediatric patients: the results of a national surveillance program in Italy-Reference-Cited by-同舟云学术

The importance of monitoring adverse drug reactions in pediatric patients: the results of a national surveillance program in Italy

Published:2014-08-29 Issue:sup1 Volume:13 Page:1-8
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Carnovale Carla,Brusadelli Tatiana,Zuccotti GianVincenzo,Beretta Silvia,Sullo Maria Giuseppa,Capuano Annalisa,Rossi Francesco,Moschini Martina,Mugelli Alessandro,Vannacci Alfredo,Laterza Marcella,Clementi Emilio,Radice Sonia,

Publisher

Informa Healthcare

Subject

Pharmacology (medical),General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14740338.2014.928692

Reference39 articles.

1. Dosing information in a standard drug reference: Are pediatrics still therapeutically neglected?

2. Dosing information for paediatric patients: are they really “therapeutic orphans”?

3. Off-Label Drug Use in Pediatric Patients

4. Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches

5. Adverse drug reactions and off-label drug use in paediatric outpatients

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 Study;Journal of Clinical Medicine;2023-11-30

2. Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system;Frontiers in Pharmacology;2023-07-10

3. Management guideline for the off-label use of medicine in China (2021);Expert Review of Clinical Pharmacology;2022-09-11

4. Guideline for the management of pediatric off-label use of drugs in China (2021);BMC Pediatrics;2022-07-23

5. Healthcare professionals and pharmacovigilance of pediatric adverse drug reactions: a 5-year analysis of Adverse Events Reporting System Database of the Food and Drug Administration;Minerva Pediatrics;2022-06